Article: A-107 A CLINICALLY RELEVANT HYBRID ADENOVIRUS- TRANSPOSON VECTOR FOR GENE THERAPY FOR VON WILLEBRAND DISEASE

Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma